PFE - What's Going On With Moderna Stock Today? | Benzinga
Moderna Inc (NASDAQ: MRNA) announced changes to its operating model to bring focus to its short- and long-term business goals.
The company is focused on driving continued sales of its COVID-19 vaccine and launching its Respiratory syncytial virus (RSV) vaccine in 2024, while also preparing to launch multiple products per year from 2025 forward.
The company has decided to increase executive focus on driving sales of Spikevax and the expected launch of its RSV vaccine next year.
Last month, the European Patent Office ...